These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31724242)

  • 41. Disease-Associated Mutations of TREM2 Alter the Processing of N-Linked Oligosaccharides in the Golgi Apparatus.
    Park JS; Ji IJ; An HJ; Kang MJ; Kang SW; Kim DH; Yoon SY
    Traffic; 2015 May; 16(5):510-8. PubMed ID: 25615530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel potent liposome agonists of triggering receptor expressed on myeloid cells 2 phenocopy antibody treatment in cells.
    Boudesco C; Nonneman A; Cinti A; Picardi P; Redaelli L; Swijsen S; Roewe J; Reinhardt P; Ibach M; Walter J; Pocock JM; Ren Y; Driguez PA; Dargazanli G; Eyquem S; Proto J; Flores-Morales A; Pradier L
    Glia; 2022 Dec; 70(12):2290-2308. PubMed ID: 35912412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders.
    Carmona S; Zahs K; Wu E; Dakin K; Bras J; Guerreiro R
    Lancet Neurol; 2018 Aug; 17(8):721-730. PubMed ID: 30033062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease.
    Giraldo M; Lopera F; Siniard AL; Corneveaux JJ; Schrauwen I; Carvajal J; Muñoz C; Ramirez-Restrepo M; Gaiteri C; Myers AJ; Caselli RJ; Kosik KS; Reiman EM; Huentelman MJ
    Neurobiol Aging; 2013 Aug; 34(8):2077.e11-8. PubMed ID: 23582655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic analysis of TREM2 variants in Chinese Han patients with sporadic Parkinson's disease.
    Tan T; Song Z; Yuan L; Xiong W; Deng X; Ni B; Chen Y; Deng H
    Neurosci Lett; 2016 Jan; 612():189-192. PubMed ID: 26704436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia.
    Li X; Montine KS; Keene CD; Montine TJ
    FASEB J; 2015 May; 29(5):1754-62. PubMed ID: 25593125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TREM2 variants and risk of Alzheimer's disease: a meta-analysis.
    Lu Y; Liu W; Wang X
    Neurol Sci; 2015 Oct; 36(10):1881-8. PubMed ID: 26037549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E.
    Bailey CC; DeVaux LB; Farzan M
    J Biol Chem; 2015 Oct; 290(43):26033-42. PubMed ID: 26374897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rare TREM2 variants associated with Alzheimer's disease display reduced cell surface expression.
    Sirkis DW; Bonham LW; Aparicio RE; Geier EG; Ramos EM; Wang Q; Karydas A; Miller ZA; Miller BL; Coppola G; Yokoyama JS
    Acta Neuropathol Commun; 2016 Sep; 4(1):98. PubMed ID: 27589997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes.
    Thelen M; Razquin C; Hernández I; Gorostidi A; Sánchez-Valle R; Ortega-Cubero S; Wolfsgruber S; Drichel D; Fliessbach K; Duenkel T; Damian M; Heilmann S; Slotosch A; Lennarz M; Seijo-Martínez M; Rene R; Kornhuber J; Peters O; Luckhaus C; Jahn H; Hüll M; Rüther E; Wiltfang J; Lorenzo E; Gascon J; Lleó A; Lladó A; Campdelacreu J; Moreno F; Ahmadzadehfar H; ; Fortea J; Indakoetxea B; Heneka MT; Wetter A; Pastor MA; Riverol M; Becker T; Frölich L; Tárraga L; Boada M; Wagner M; Jessen F; Maier W; Clarimón J; López de Munain A; Ruiz A; Pastor P; Ramirez A
    Neurobiol Aging; 2014 Nov; 35(11):2657.e13-2657.e19. PubMed ID: 25042114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.
    Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A
    J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TREM2 regulates innate immunity in Alzheimer's disease.
    Li JT; Zhang Y
    J Neuroinflammation; 2018 Apr; 15(1):107. PubMed ID: 29655369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TREM2 and the Progression of Alzheimer's Disease.
    Gao L; Jiang T; Yao X; Yu L; Yang X; Li Y
    Curr Neurovasc Res; 2017; 14(2):177-183. PubMed ID: 28393702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
    J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for TLR4 and FcRγ-CARD9 activation by cholera toxin B subunit and its direct bindings to TREM2 and LMIR5 receptors.
    Phongsisay V; Iizasa E; Hara H; Yoshida H
    Mol Immunol; 2015 Aug; 66(2):463-71. PubMed ID: 26021803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microglial signalling pathway deficits associated with the patient derived R47H TREM2 variants linked to AD indicate inability to activate inflammasome.
    Cosker K; Mallach A; Limaye J; Piers TM; Staddon J; Neame SJ; Hardy J; Pocock JM
    Sci Rep; 2021 Jun; 11(1):13316. PubMed ID: 34172778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigation of triggering receptor expressed on myeloid cells 2 variant in the Wisconsin Registry for Alzheimer's Prevention.
    Engelman CD; Koscik RL; Jonaitis EM; Hermann BP; La Rue A; Sager MA
    Neurobiol Aging; 2014 Jun; 35(6):1252-4. PubMed ID: 24378087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices.
    Lue LF; Schmitz CT; Serrano G; Sue LI; Beach TG; Walker DG
    Brain Pathol; 2015 Jul; 25(4):469-80. PubMed ID: 25186950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of FAK/Rac1/Cdc42-GTPase signaling ameliorates impaired microglial migration response to Aβ
    Rong Z; Cheng B; Zhong L; Ye X; Li X; Jia L; Li Y; Shue F; Wang N; Cheng Y; Huang X; Liu CC; Fryer JD; Wang X; Zhang YW; Zheng H
    FASEB J; 2020 Aug; 34(8):10984-10997. PubMed ID: 32613609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer's disease.
    Toomey CE; Heywood W; Benson BC; Packham G; Mills K; Lashley T
    Brain Pathol; 2020 Jul; 30(4):794-810. PubMed ID: 32267026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.